Atrys Chile and the Universidad Mayor, one of the most innovative private universities in the country, have formalized a Framework Collaboration Agreement, a strategic alliance that seeks to develop joint projects in digital health, research, academic training and health impact assessment. 

The agreement, the first between Atrys and a Chilean university, was celebrated at an institutional event attended by the Rector of Universidad Mayor, the Dean of the Faculty of Medicine and Health Sciences, academic authorities and the management team of Atrys Chile. 

The agreement includes five strategic axes: the design of hybrid healthcare models with technologies such as AI and telemedicine; collaborative teaching and research programs; development of virtual clinical fields; evaluation of the healthcare impact of new medical solutions; and joint projects with the public healthcare network to resolve waiting lists. Noteworthy initiatives include the creation of a virtual clinical campus, the measurement of the health impact of Atrys’ services, the publication of Atrys’ innovative health experiences, and the participation in joint pilots to validate new initiatives. 

This agreement reinforces Atrys’ commitment to quality care, innovation and the strengthening of the healthcare ecosystem in Chile. Santiago de Torres, non-executive chairman of Atrys, stated that “through this strategic collaboration, we will drive technological integration and generate innovations that will transform the healthcare system in Chile, achieving higher quality and more accessible healthcare at a national level”. 

This new alliance joins a series of strategic collaborations that Atrys maintains with the academic world, such as the Universidad Nacional Abierta y a Distancia de Colombia (UNAD), and with leading institutions in Spain such as the Complutense, Autónoma de Madrid, Granada and Barcelona Universities. With the latter, we consolidated our relationship through the UB Atrys Chair of Radiation Oncology, which this year celebrates the IV edition of its prestigious Research Awards in Personalized Radiotherapy.